Hospitals improve financial performance, but volumes are slipping

Last year was generally a year of financial improvement for hospitals, with profitability in 2018 demonstrating growth in operating margin of about 5 percent compared to 2017, and outperforming budget by 4.4 percent, according to a new Kaufman Hall analysis. But increasing their volumes is still a struggle for hospitals, and they underperformed in that area last year as compared to 2017. The underperformance in volume was a trend that held nationally for the most part, with discharges remaining steadily in decline. Unfavorable performance in emergency department visits continued to accelerate, and while adjusted discharges and adjusted patient days increased, the increase slowed last year compared to 2017.

Spotlight

Other News
Healthcare Analytics

FDA Grants De Novo for Xenex's LightStrike+ UV Robot in Healthcare

Xenex | September 11, 2023

United States Food and Drug Administration (USFDA) has issued a De Novo authorization to Xenex Disinfection Services, Inc. (Xenex) for its LightStrikeTM+ device, an advanced high-intensity, broad-spectrum ultraviolet (UV) light robot. The LightStrike+ devices are designed for microbial reduction on non-critical medical device surfaces in healthcare environments, following manual cleaning and disinfection practices. They are authorized for use in various healthcare settings, including unoccupied operating rooms and hospital rooms. These devices have an impressive track record, with over 1,200 healthcare facilities worldwide employing LightStrike robots for over 37 million cycles. The new LightStrike+ device, capable of microbial reduction in as little as 2 minutes, represents the culmination of over a decade of knowledge accumulation from healthcare facilities' best practices, supported by 45 peer-reviewed studies demonstrating its safety and effectiveness, a portfolio of 193 patents, and unparalleled technical and epidemiological expertise. Dr. Mark 'Tuck' Stibich, Xenex's Founder and Chief Scientific Officer, emphasized the long-standing collaboration with healthcare partners spanning more than a decade to enhance patient safety and public health. As an infectious diseases epidemiologist, Dr. Stibich expressed concern about antibiotic resistance within hospital environments and the potential for FDA authorization to facilitate the broader adoption of the LightStrike+ tool in combating pathogens. Perilous pathogens persist on surfaces within healthcare facilities, notwithstanding diligent manual cleaning endeavors. The LightStrike+ robot employs a xenon lamp to generate high-intensity pulsed UV light, which effectively diminishes the presence of these pathogens on surfaces and plays a pivotal role in interrupting the transmission chain from one patient or healthcare worker to another. Xenex's FDA authorization is substantiated by comprehensive testing conducted on more than 10,000 samples of vegetative bacteria and Clostridiodes difficile (C. diff) spores. This authorization establishes a novel medical device product classification, with the LightStrike+ robot being its inaugural and sole product. It is a landmark in the FDA's regulatory framework for UV robots designed to diminish pathogens on non-porous, frequently touched surfaces within healthcare settings. Furthermore, Xenex's Chief Executive Officer, Morris Miller, acknowledged the challenges hospitals face when evaluating UV technologies, citing the prevalence of unverified and exaggerated claims by some manufacturers. He underscored the significance of FDA authorization in instilling confidence among hospital decision-makers, assuring them of the accuracy and validation of Xenex's claims regarding the LightStrike+ device. Numerous world-renowned hospitals, such as HonorHealth, Mayo Clinic, MD Anderson Cancer Center, Ochsner Health System, Stanford Health Care, and Texas Health Resources, have integrated LightStrike robots into their comprehensive disinfection strategies. About Xenex Xenex is a global leader in pioneering strategies and solutions grounded in UV technology. Its fundamental mission revolves around enabling its partners to safeguard lives and reduce human suffering by eliminating the dangerous microorganisms that cause infections. The company benefits from substantial support from renowned investors, including EW Healthcare Partners, Piper Sandler, Malin Corporation, Battery Ventures, Targeted Technology Fund II, Tectonic Ventures, and RK Ventures.

Read More

Healthcare Analytics

Weave Introduces AI-Driven Voicemail Transcriptions for Healthcare Providers

Business Wire | October 31, 2023

Weave a leading all-in-one experience platform for small and medium-sized healthcare practices, today announces the addition of AI-driven voicemail transcriptions to its platform. Now available to Weave’s 27,000+ customers, Voicemail Transcription automatically transcribes voicemails from patients allowing for efficient, visible, and private reading experiences. With this update, users will now see the voicemail transcription when they click on the Voicemail tab within their Desktop Application or within the mobile app, improving overall user experience by making it faster to consume messages without having to listen to the audio, which can often be difficult in busy settings. said Branden Neish, Chief Product and Technology Officer at Weave. AI has exploded in popularity over the past year, and we’re taking steps to ensure Weave is delivering state of the art offerings that empower our customers to enhance patient experiences and deliver top of the line care. AI will only continue to grow in popularity and daily use, which will have a transformative impact on the future of the healthcare industry. Weave customers that have already implemented AI into their practices claim they save an average of an hour a day with the technology. [Source:Business Wire] In a new customer and consumer report conducted by Weave, the company found that patients are accepting of AI in healthcare settings and they see it leading to enhanced care and patient experiences. In fact, the majority of consumers (65%) are open to providers using AI tools in their practices. The report also found that consumers and providers are aligned with how they think AI will impact the healthcare industry, with two in three consumers (67%) and 3 in 4 (75%) healthcare providers believing that AI is likely to become a prevalent tool in healthcare. "Artificial Intelligence is the catalyst for a new era in healthcare,” says Dr. Matt Nejad, DDS of Beverly Hills, CA. “Weave's AI-enabled voicemail transcripts are a leap in this direction, providing automation and actionable insights that empower providers to focus on what truly matters: patient care." This announcement follows months of AI-driven activity from Weave to enhance features that allow healthcare providers to deliver quality care and improve patient experiences, including Email Assistant and Response Assistant. About Weave Weave is a leading all-in-one customer experience platform for small- and medium-sized healthcare businesses. From the first phone call to the final invoice and every touchpoint in between, Weave connects the entire customer journey. Weave’s software solutions transform how local businesses attract, communicate with and engage customers to grow their business. In the past year, Weave has been named a G2 leader in Patient Engagement, Optometry, Dental Practice Management and Patient Relationship Management software.

Read More

Health Technology

Absolute Software New Application Health Monitoring Extends Cyber Resilience to Leading Endpoint Security and Productivity Applications

Business Wire | November 02, 2023

Absolute Software™, the leading provider of self-healing, intelligent security solutions, today announced the launch of Absolute Application Health. This new feature empowers digital enterprises to strengthen cyber resilience and boost end user productivity with the industry’s most resilient application health monitoring capabilities. With this latest innovation to the company’s Secure Endpoint product line, customers can monitor the health of more than 2,000 commonly used Windows and Mac applications – including security controls, business, and productivity tools – to ensure they are installed, running, and properly configured on all devices. “Organizations deploy millions of endpoint devices to support growing remote workforces around the world, and they invest billions of dollars into security controls needed to protect their networks against advanced threats and costly compliance violations,” said Sarah Pavlak, Industry Principal, Frost & Sullivan. “Despite all these efforts and money spent, organizations continue to experience increasing attacks and complexity challenges that severely disrupt business operations. This is leading to a continual need for innovations that can mitigate software failures and close security gaps.” Absolute’s 2023 Resilience Index reveals that on average, enterprise endpoint devices have 67 applications deployed, with 10 percent of these having more than 100 applications installed. In analyzing 10 of the most widely deployed security tools, the report also shows seven of those 10 apps were installed and healthy on less than 80 percent of deployed devices, on average. In some cases, apps were only functioning correctly 47 percent of the time. said John Herrema, Chief Product Officer, Absolute Software. Today’s digital enterprises are investing billions of dollars in mission-critical security and business tools, and we believe those applications should deliver their intended value. The complexity and fragility of endpoint applications, however, means that all too often they are failing. And if the tool you use to monitor your other applications is subject to those same failures, then you’re really in trouble, because it’s impossible to fix what you can’t reliably see or diagnose. This latest innovation builds on Absolute’s unique Persistence technology to provide the industry’s most resilient visibility and monitoring capabilities. This allows our customers to achieve maximum security, productivity, and return on their software investments. [Source:Business Wire] With Absolute Application Health, IT and security practitioners gain the deep visibility needed to ensure applications are installed, running, up-to-date, and properly configured across their entire device fleet. They also have access to detailed, interactive reports and widgets that enable them to swiftly diagnose why an application is failing and then take remedial action. Embedded in the firmware of more than 600 million devices, Absolute’s patented Persistence® technology provides a secure, always-on connection between the Absolute Platform and the endpoint. The new Application Health feature leverages this digital tether to ensure health monitoring and reporting remains uninterrupted. Absolute Application Health is available now to Absolute Secure Endpoint customers subscribed to eligible Absolute Resilience licenses. For more information, including how to access and activate this new feature, visit our latest blog. About Absolute Software Absolute Software makes security work. We empower mission-critical performance with advanced cyber resilience. Embedded in more than 600 million devices, our cyber resilience platform delivers endpoint-to-network access security coverage, ensures automated security compliance, and enables operational continuity. Nearly 21,000 global customers trust Absolute to protect enterprise assets, fortify security and business applications, and provide a frictionless, always-on user experience.

Read More

Health Technology, Digital Healthcare

Virgin Pulse and HealthComp Announce Intent to Merge to Create Comprehensive Employer Health Platform

PR Newswire | September 29, 2023

Virgin Pulse, a leading global digital-first health, wellbeing, and navigation company, today announced its intent to merge with HealthComp, a next-generation benefits and analytics platform. The merger will create a technology and data powered health platform-as-a-service organization poised to tackle some of the industry's biggest challenges. The combined entity will aim to improve health outcomes and lower costs for members and employers by empowering better information and decision making. By using an advanced technology and data platform that leverages AI, the combined organization will deploy innovative and flexible health plan designs that drive improved member health outcomes, engagement, and awareness across the most important aspects of a person's healthcare journey. As the healthcare industry evolves, the desire for an integrated experience in the employer-sponsored benefits ecosystem has grown exponentially. This combination will create a set of assets that will integrate plan design, plan management, payment integrity, health navigation, preventative care, and digital therapeutics through the Homebase for Health® user-centric platform. Together, the combined entity expects these assets will create a better experience and lower costs for members and employers, while providing expanded opportunities for insurers and brokers to continue to partner with the combined entity. "This combination with HealthComp creates a new category in the health space that will change the way employers address the two-fold challenge of reducing costs and improving member outcomes. Our two companies have a shared mission to improve individual outcomes by engaging users early and often, and making health and wellbeing more accessible, affordable, and personal for all," said Chris Michalak, Virgin Pulse CEO. "Together, we are addressing a problem that has plagued the industry for years – a misaligned, complex benefit structure that results in unmet needs and escalating costs. We are eliminating waste, friction, and preventable risks by putting members and their needs at the center of the ecosystem." "Self-insured employers pay for almost half of the nation's healthcare expenditures and now require more innovative and affordable solutions," said Chad Harris, HealthComp CEO. "With concierge-level service, rich analytics, and expert medical cost management, HealthComp ensures that employers can make informed benefits decisions that align with the needs of their employees and businesses. Powered by Virgin Pulse's daily wellbeing engagement and data-driven personalization, this transaction creates an end-to-end platform that will radically lower costs and improve member outcomes." [Source – PRNews Wire] "The combination of Virgin Pulse and HealthComp creates the first national value-based care platform company focused on employee health and outcomes. We are excited to work with Morgan Health, Blackstone, and Marlin to bring innovation at scale to this market," said Matt Holt, President, Private Equity and Managing Director at New Mountain Capital. "We have been working to build an innovation platform company in the employer space for more than five years. This transaction represents a significant milestone by forming a leading platform-as-a-service company focused on delivering better outcomes and greater affordability," added Kyle Peterson, Managing Director at New Mountain Capital. "The employer-employee health landscape is ripe for change and the mission of the combined HealthComp and Virgin Pulse is aligned with Morgan Health's mission to improve the quality, equity, and affordability of employer-sponsored health care," said Dan Mendelson, CEO of Morgan Health. Upon closing of the transaction, Chris Michalak will serve as CEO of the combined entity, where he will continue building upon the Homebase for Health vision and expanding the value proposition for clients and the market at large. The combined entity will serve more than 20 million members and address costs for more than 1,000 self-insured employers. HealthComp's powerful analytics will also benefit Virgin Pulse's health plan and health system clients by providing closed-loop data on health outcomes and the true ROI of investing in member experience and wellbeing programs. The merger is expected to close in Q4 2023, subject to regulatory approvals and satisfaction of all closing conditions under the definitive agreement. Financial details of the transaction have not been disclosed. HealthComp is backed by New Mountain Capital and Virgin Pulse is backed by Marlin Equity Partners. New Mountain Capital will be the majority owner of the combined entity. Blackstone Credit has committed to support the deal with strategic financing. J.P. Morgan Securities LLC acted as financial advisor to HealthComp. HealthComp's legal counsel was Ropes & Gray LLP. Evercore acted as financial advisor to Virgin Pulse, with Kirkland & Ellis LLP and McDermott Will & Emery LLP serving as legal advisors. About Virgin Pulse Virgin Pulse is a leading digital-first health, wellbeing, and navigation company that empowers organizations across the globe to activate populations, improve health outcomes, and reduce spend in an era of accelerating cost and complexity. Virgin Pulse's Homebase for Health® connects data, people, and technology to deliver high tech, human touch experiences that engage and reward individual journeys. Virgin Pulse impacts over 100 million people across 190 countries by helping Fortune 500, national health plans, and many other organizations change lives – and businesses – for good. About HealthComp HealthComp, a New Mountain Capital company, has a customized and responsive approach to health benefits administration. We advocate for our members to get the best possible care suited for their unique needs. Our next generation benefits and analytics platform brings together concierge-level service, best-in-class operations, powerful analytics, and expert medical cost management. HealthComp integrates seamlessly with any benefits ecosystem to drive a personalized experience that delivers higher clinical outcomes at lower costs. HealthComp has offices in California, Illinois, Kentucky, West Virginia, Louisiana, and Pennsylvania. About New Mountain Capital New Mountain Capital is a New York-based investment firm that emphasizes business building and growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, credit and net lease investment strategies with over $45 billion in assets under management. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. About Marlin Equity Partners Marlin Equity Partners is a global investment firm with approximately $9 billion of capital commitments. The firm is focused on providing corporate parents, shareholders and other stakeholders with tailored solutions that meet their business and liquidity needs. Marlin invests in businesses across multiple industries where its capital base, industry relationships and extensive network of operational resources significantly strengthen a company's outlook and enhance value. Since its inception, Marlin, through its group of funds and related companies, has successfully completed over 200 acquisitions. About Morgan Health Morgan Health is a JPMorgan Chase business unit focused on improving employer-sponsored health care. Through its investments and the advancement of accountable care, Morgan Health is working to improve the quality, equity and affordability of employer-sponsored health care for JPMorgan Chase employees, their families and the U.S. health system. The business is led by Dan Mendelson, CEO of Morgan Health, reporting to Peter Scher, Vice Chairman of JPMorgan Chase & Co. and a member of the firm's Operating Committee. Morgan Health is headquartered in Washington, D.C. About Blackstone Blackstone is the world's largest alternative asset manager. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. We do this by using extraordinary people and flexible capital to help companies solve problems. Our $1 trillion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, infrastructure, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis.

Read More